Cargando…

Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism

BACKGROUND: Patients with intermediate-high risk pulmonary embolism (PE) who have acute right ventricular dysfunction and myocardial injury without overt hemodynamic compromise may be candidates for thrombolytic therapy (TT). In this study, we aimed to compare the clinical outcomes of low-dose prolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Surgit, Ozgur, Güner, Ahmet, Türkmen, İrem, Kahraman, Serkan, Serbest, Nail Guven, Güner, Ezgi Gültekin, UZUN, FATİH, Ertürk, Mehmet, Yildiz, Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315937/ https://www.ncbi.nlm.nih.gov/pubmed/37278082 http://dx.doi.org/10.14744/tjtes.2023.55236

Ejemplares similares

Treatment approach to coronary aneurysms: percutaneous or surgical?
por: Güner, Ahmet, et al.
Publicado: (2020)

Pros and Cons of a Novel Coronary Stenting Technique for Medina 0.0.1 Lesions: Osdokina Crush
por: Güner, Ahmet, et al.
Publicado: (2023)

Clinical Value of Tp-e/QTc Ratio in Patients Undergoing Coronary Angiography for Acute Coronary Syndrome
por: Güner, Ezgi Gültekin, et al.
Publicado: (2022)

Reply to Letter to the Editor: Provisional (Reverse) Double-Kissing Nano-Culotte Stenting
por: Kahraman, Serkan, et al.
Publicado: (2023)

Critique of “Dramatical Response to Low Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis”
por: Gültekin Güner, Ezgi, et al.
Publicado: (2022)

Management of Coronary Embolism in a Patient With Aortic Mechanical Prosthetic Heart Valve Thrombosis
por: Güner, Ahmet, et al.
Publicado: (2021)

The Predictors of Asymptomatic Cerebral Embolism After Carotid Artery Stenting
por: Güner, Ahmet, et al.
Publicado: (2022)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Author`s Reply
por: Güner, Ahmet, et al.
Publicado: (2019)

Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?
por: Güner, Ahmet, et al.
Publicado: (2021)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
por: Garcia, Flávio Luís, et al.
Publicado: (2015)

Structural Changes of the Right Fibrous Trigone as a Risk Factor for Conduction Disturbance After Transcatheter Aortic Valve Implantation
por: Aslan, Serkan, et al.
Publicado: (2022)

Two and real-time three dimensional transesophageal echocardiography guided thrombolytic therapy for prosthetic valve thrombosis is crucial
por: Guner, Ahmet, et al.
Publicado: (2018)

Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments
por: Davenport, Andrew
Publicado: (2012)

Impact of COVID-19 on monitoring of therapeutic unfractionated heparin
por: Adie, Sarah K., et al.
Publicado: (2020)

Quantitative Analysis of Impurities in Unfractionated Heparin of Bovine Origin
por: Workman, Wesley E., et al.
Publicado: (2020)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

Resistance to unfractionated heparin in the ICU: evaluation and management options
por: Levy, Jerrold H., et al.
Publicado: (2023)

Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome
por: Seaman, Craig D., et al.
Publicado: (2020)

Antiplatelet resistance and the role of associated variables in stable patients treated with stenting
por: Uzun, Fatih, et al.
Publicado: (2015)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
por: McGarry, Lisa J, et al.
Publicado: (2006)

Opposition: Unfractionated heparin should no longer be used in the catheterization laboratory
por: Kim, Moo Hyun, et al.
Publicado: (2014)

Administration of Direct Oral Anticoagulant Immediately after Unfractionated Heparin Bolus for the Treatment of Intermediate–High-Risk Pulmonary Thromboembolism
por: Hara, Nobuhiro, et al.
Publicado: (2020)

Low-Molecular-Weight Heparin and Unfractionated Heparin Decrease Th-1, 2, and 17 Expressions
por: Huang, Jing-Ning, et al.
Publicado: (2014)

Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin
por: Maharaj, Satish, et al.
Publicado: (2018)

Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022)

Transabdominal Migration of Retained Surgical Sponge
por: Guner, Ali, et al.
Publicado: (2012)

Distinct Effects of Unfractionated Heparin versus Bivalirudin on Circulating Angiogenic Peptides
por: Kapur, Navin K., et al.
Publicado: (2012)

Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity
por: Li, Binghan, et al.
Publicado: (2016)

Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin
por: Kalaska, Bartlomiej, et al.
Publicado: (2015)

Individual variation in unfractionated heparin dosing after pediatric cardiac surgery
por: Hikino, Keiko, et al.
Publicado: (2020)

Validation of high concentrated thrombin time assay for unfractionated heparin monitoring
por: Apipongrat, Dollapak, et al.
Publicado: (2022)

Predicting Therapeutic Response to Unfractionated Heparin Therapy: Machine Learning Approach
por: Abdel-Hafez, Ahmad, et al.
Publicado: (2022)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
por: Amin, Alpesh, et al.
Publicado: (2023)

The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
por: Afshari, Daryoush, et al.
Publicado: (2015)

Long-term prognostic value of admission haemoglobin A(1c) (HbA(1c)) levels in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Pusuroglu, Hamdi, et al.
Publicado: (2014)

Management of an acute ischemic stroke during thrombolytic treatment in a pregnant patient with prosthetic valve thrombosis
por: Kalçık, Macit, et al.
Publicado: (2017)

Abdominal wall blocks for emergency ileostomy operation in a patient with COVID-19 pneumonia: a case report
por: Guven, Bulent Baris, et al.
Publicado: (2021)

A comparative study of dalteparin and unfractionated heparin in patients with unstable angina pectoris
por: Amane, Hanmant S., et al.
Publicado: (2011)

Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease
por: Nicholson, Tricia, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_l0fm5jeuojn4i07qkq2klu62fu